Cerflux

Provider of personalized cancer treatment selection tests. It offers a patented test that screens multiple therapy agents simultaneously on a patient's tumor biopsy tissue. This allows for the identification of effective

placeBirmingham, Alabama, United States calendar_todayFounded 2015 groups8 employees language cerflux.com

Registered entities

Investor mix

5 investors on record; lead investors include Alabama Launchpad.

Investor typeCountShare
Venture capital120%
Other / undisclosed480%
Coming soon